IV to SC Formulation Support

About QATCH Technologies

QATCH Technologies is a privately held instrumentation company focused on the biopharmaceutical development sector. Its core innovation is a sensor-based platform that measures viscosity and injectability using only microliter sample volumes, addressing a critical bottleneck in formulating biologics for subcutaneous delivery. The company appears to be in an early commercial stage, generating revenue through the sale of its benchtop instruments (nanovisQ series) and a viscosity testing service while continuing platform development with its visQ.AI software. Its value proposition centers on accelerating and de-risking drug development by providing formulation scientists with precise, predictive data on manufacturability and patient injectability early in the preclinical process.